Val S. Goodfellow

958 citations

28 papers · 802 indexed · h-index 17

Co-authors: John Saunders Petra Hirsova Gregory J. Gores Nathan W. Werneburg Samar H. Ibrahim Kyoko Tomita Harmeet Malhi Steven F. Bronk
Topics: Biochemical Analysis and Sensing Techniques (13 papers)Regulation of Appetite and Obesity (12 papers)Receptor Mechanisms and Signaling (8 papers)
Cited by: Endocrine and Autonomic Systems Nutrition and Dietetics Virology
Journals: Journal of Neuroscience Circulation Research Hepatology
Partner nations: United States Czechia Germany

In The Last Decade

Val S. Goodfellow

28 papers receiving 770 citations

Peers

Countries citing papers authored by Val S. Goodfellow

Since Specialization

Citations

This map shows the geographic impact of Val S. Goodfellow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Val S. Goodfellow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Val S. Goodfellow more than expected).

Fields of papers citing papers by Val S. Goodfellow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Val S. Goodfellow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Val S. Goodfellow. The network helps show where Val S. Goodfellow may publish in the future.

Co-authorship network of co-authors of Val S. Goodfellow

This figure shows the co-authorship network connecting the top 25 collaborators of Val S. Goodfellow. A scholar is included among the top collaborators of Val S. Goodfellow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Val S. Goodfellow. Val S. Goodfellow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss 2019 ·Experimental Neurology ·(unknown),Laura M. Butkovich,Joshua M. Bradner,Jianjun Chang,Harris A. Gelbard,Val S. Goodfellow,W. Michael Caudle,Malú G. Tansey	10
2	The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy 2015 ·Nanomedicine Nanotechnology Biology and Medicine ·Gang Zhang,Dongwei Guo,Prasanta K. Dash,Mariluz Araínga,(unknown),Nicole A. Haverland,(unknown),(unknown),Paweł Ciborowski,Val S. Goodfellow,Tadeusz A. Wysocki,Beata J. Wysocki,Larisa Y. Poluektova,Xin-Ming Liu,JoEllyn McMillan,Santhi Gorantla,Harris A. Gelbard,Howard E. Gendelman	24
3	Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes 2015 ·Hepatology ·Samar H. Ibrahim,Petra Hirsova,Kyoko Tomita,Steven F. Bronk,Nathan W. Werneburg,Stephen A. Harrison,Val S. Goodfellow,Harmeet Malhi,Gregory J. Gores	201
4	The New Small-Molecule Mixed-Lineage Kinase 3 Inhibitor URMC-099 Is Neuroprotective and Anti-Inflammatory in Models of Human Immunodeficiency Virus-Associated Neurocognitive Disorders 2013 ·Journal of Neuroscience ·Daniel F. Marker,Marie‐Ève Tremblay,(unknown),Joseph Barbieri,(unknown),Colin J. Loweth,E. Chris Muly,Shao‐Ming Lu,Val S. Goodfellow,Stephen Dewhurst,Harris A. Gelbard	50
5	Synthesis and structure–activity relationships of spirohydantoin-derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1) 2007 ·Bioorganic & Medicinal Chemistry Letters ·Martin W. Rowbottom,(unknown),(unknown),Mingzhu Zhang,Brian Dyck,(unknown),David Schwarz,Christopher E. Heise,(unknown),Jenny Wen,Hui Tang,Hua Wang,Andrew J. Fisher,Anna Aparicio,John Saunders,Val S. Goodfellow	8
6	Synthesis and structure–activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Mehrak Kiankarimi,Martin W. Rowbottom,(unknown),Dongpei Wu,Joseph Pontillo,(unknown),(unknown),Val S. Goodfellow,David Schwarz,Christopher E. Heise,Ajay Madan,Jenny Wen,(unknown),Hua Wang,Warren S. Wade	9
7	Synthesis and structure–activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1 2006 ·Bioorganic & Medicinal Chemistry Letters ·Martin W. Rowbottom,(unknown),Brian Dyck,(unknown),(unknown),Mingzhu Zhang,Mehrak Kiankarimi,Dongpei Wu,(unknown),Warren S. Wade,David Schwarz,Christopher E. Heise,Ajay Madan,Andrew J. Fisher,Robert E. Petroski,Val S. Goodfellow	6
8	Substituted chromones and quinolones as potent melanin-concentrating hormone receptor 1 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Brian Dyck,(unknown),(unknown),Joseph Pontillo,(unknown),(unknown),Christopher E. Heise,Jenny Wen,(unknown),Ajay Madan,David Schwarz,Warren S. Wade,Val S. Goodfellow	14
9	Manipulation of small-molecule inhibitory kinetics modulates MCH-R1 function 2006 ·Molecular and Cellular Endocrinology ·David Schwarz,(unknown),Robert E. Petroski,Jordan E. Pomeroy,Christopher E. Heise,(unknown),Julie V. Selkirk,Lisa Nottebaum,(unknown),Mingzhu Zhang,Val S. Goodfellow,Richard A. Maki	1
10	1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Charles Q. Huang,Tracy J. Baker,David Schwarz,Jun Fan,Christopher E. Heise,Mingzhu Zhang,Val S. Goodfellow,Stacy Markison,Kathleen R. Gogas,Takung Chen,Xiaochuan Wang,Yunfei Zhu	28
11	Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazines 2005 ·Bioorganic & Medicinal Chemistry Letters ·Fábio C. Tucci,(unknown),Stacy Markison,Margaret Joppa,Joe A. Tran,Beth A. Fleck,Ajay Madan,Brian Dyck,Jessica Parker,Joseph Pontillo,(unknown),Dragan Marinković,Wanlong Jiang,Caroline W. Chen,Kathleen R. Gogas,Val S. Goodfellow,John Saunders,Alan C. Foster,Chen Chen	30
12	Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Brian Dyck,Martin W. Rowbottom,(unknown),(unknown),Mingzhu Zhang,(unknown),Christopher E. Heise,David Schwarz,John Saunders,Val S. Goodfellow	20
13	Potent imidazole and triazole CB 1 receptor antagonists related to SR141716 2004 ·Bioorganic & Medicinal Chemistry Letters ·Brian Dyck,Val S. Goodfellow,Teresa A. Phillips,(unknown),Mustapha Haddach,Martin W. Rowbottom,Gregory S. Naeve,Brock Brown,John Saunders	56
14	Assessment of a small molecule melanocortin-4 receptor-specific agonist on energy homeostasis 2004 ·Brain Research ·(unknown),Teresa A. Phillips,(unknown),Val S. Goodfellow,Nick Ling,Roger D. Cone,Wei Fan	28
15	Potent Imidazole and Triazole CB₁ Receptor Antagonists Related to SR141716. 2004 ·ChemInform ·Brian Dyck,Val S. Goodfellow,Teresa A. Phillips,(unknown),Mustapha Haddach,Martin W. Rowbottom,Gregory S. Naeve,Brock Brown,(unknown)	4
16	Aryl piperazine melanocortin MC4 receptor agonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Brian Dyck,Jessica Parker,Teresa Phillips,(unknown),Brian J. Murphy,(unknown),(unknown),Tracy J. Baker,(unknown),John Saunders,Val S. Goodfellow	40
17	The Melanocortin System and its Role in Obesity and Cachexia 2003 ·Current Topics in Medicinal Chemistry ·Val S. Goodfellow,John Saunders	36
18	Body Weight Regulation by Selective MC4 Receptor Agonists and Antagonists 2003 ·Annals of the New York Academy of Sciences ·Alan C. Foster,Margaret Joppa,Stacy Markison,K.R. Gogas,Beth A. Fleck,Brian J. Murphy,(unknown),Mary J. Cismowski,Nicholas Ling,Val S. Goodfellow,Chen Chen,John Saunders,Paul Conlon	21
19	Bradykinin antagonists in human systems: Correlation between receptor binding, calcium signalling in isolated cells, and functional activity in isolated ileum 1997 ·Biochemical Pharmacology ·Maciej Wieczorek,(unknown),Michael Burkard,John S. Zuzack,Steven W. Jones,Mary D. Francis,Virginia E. Beckey,Sherman Ross,Val S. Goodfellow,(unknown),(unknown),(unknown),(unknown),William M. Selig,John M. Stewart,Lajos Gera,Eric T. Whalley	4
20	Rationally designed non-peptides: Variously substituted piperazine libraries for the discovery of bradykinin antagonists and other G-protein-coupled receptor ligands 1996 ·Molecular Diversity ·Val S. Goodfellow,Christopher P. Laudeman,(unknown),Michael Burkard,(unknown),John S. Zuzack,(unknown)	26

About Val S. Goodfellow

Val S. Goodfellow is a scholar working on Endocrine and Autonomic Systems, Nutrition and Dietetics and Virology, having authored 28 papers that have together received 802 indexed citations. Recurring topics across this work include Biochemical Analysis and Sensing Techniques (13 papers), Regulation of Appetite and Obesity (12 papers) and Receptor Mechanisms and Signaling (8 papers). The work is most often cited by research in Endocrine and Autonomic Systems (194 citations), Nutrition and Dietetics (196 citations) and Virology (40 citations). Val S. Goodfellow has collaborated with scholars based in United States, Czechia and Germany. Frequent co-authors include John Saunders, Petra Hirsova, Gregory J. Gores, Nathan W. Werneburg, Samar H. Ibrahim, Kyoko Tomita, Harmeet Malhi, Steven F. Bronk, Stephen A. Harrison and Brian Dyck. Their work appears in journals such as Journal of Neuroscience, Circulation Research and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact